1. Home
  2. GOGO vs AUPH Comparison

GOGO vs AUPH Comparison

Compare GOGO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOGO
  • AUPH
  • Stock Information
  • Founded
  • GOGO 1991
  • AUPH 1993
  • Country
  • GOGO United States
  • AUPH Canada
  • Employees
  • GOGO N/A
  • AUPH N/A
  • Industry
  • GOGO Telecommunications Equipment
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOGO Consumer Discretionary
  • AUPH Health Care
  • Exchange
  • GOGO Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • GOGO 1.0B
  • AUPH 1.1B
  • IPO Year
  • GOGO 2013
  • AUPH 1999
  • Fundamental
  • Price
  • GOGO $14.26
  • AUPH $7.77
  • Analyst Decision
  • GOGO Buy
  • AUPH Strong Buy
  • Analyst Count
  • GOGO 3
  • AUPH 2
  • Target Price
  • GOGO $11.33
  • AUPH $11.50
  • AVG Volume (30 Days)
  • GOGO 2.1M
  • AUPH 1.1M
  • Earning Date
  • GOGO 08-06-2025
  • AUPH 07-31-2025
  • Dividend Yield
  • GOGO N/A
  • AUPH N/A
  • EPS Growth
  • GOGO N/A
  • AUPH N/A
  • EPS
  • GOGO N/A
  • AUPH 0.27
  • Revenue
  • GOGO $570,694,000.00
  • AUPH $247,295,000.00
  • Revenue This Year
  • GOGO $107.44
  • AUPH $12.15
  • Revenue Next Year
  • GOGO $5.66
  • AUPH $18.31
  • P/E Ratio
  • GOGO N/A
  • AUPH $29.21
  • Revenue Growth
  • GOGO 41.51
  • AUPH 29.20
  • 52 Week Low
  • GOGO $6.17
  • AUPH $5.20
  • 52 Week High
  • GOGO $15.10
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • GOGO 76.56
  • AUPH 38.94
  • Support Level
  • GOGO $11.30
  • AUPH $8.08
  • Resistance Level
  • GOGO $15.10
  • AUPH $8.29
  • Average True Range (ATR)
  • GOGO 0.71
  • AUPH 0.19
  • MACD
  • GOGO 0.21
  • AUPH -0.03
  • Stochastic Oscillator
  • GOGO 83.68
  • AUPH 5.00

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: